The wild-type Ras: Road ahead

FASEB Journal

Volumn 19, Issue 2, 2005, Pages 161-169

  Singh, Arvind ^a   Sowjanya, A Pavani ^a   Ramakrishna, Gayatri ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

Cyclin dependent kinase inhibitors (CDKIs); Mutant ras; Ras GDP; Ras GTP

Indexed keywords

GROWTH FACTOR RECEPTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; RAS GUANOSINE DIPHOSPHATE; RAS GUANOSINE TRIPHOSPHATE; RAS PROTEIN; UNCLASSIFIED DRUG;

ALLELE; CELL CULTURE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH DISORDER; ONCOGENE RAS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; UPREGULATION;

ANIMALS; GENES, RAS; HUMANS;

EID: 13244283290     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2584hyp     Document Type: Review

References (87)

1. Pfeifer, G. P. (2001) A new verdict for an old convict. Nat. Genet. 29, 3-4
2. Spandidos, D. A., Sourvinos, G., Tsatsanis, C., and Zafiropoulos, A. (2002) Normal ras genes: their onco-suppressor and proapoptotic functions. Int. J. Oncol. 21, 237-241
3. Shields, J. M., Pruitt, K., McFall, A., Shaub, A., and Der, C. J. (2000) Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol. 10, 147-154
4. Hamad, N. M., Elconin, J. H., Karnoub, A. E., Bai, W., Rich, J. N., Abraham, R. T., Der, C. J., and Counter, C. M. (2002) Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16, 2045-2057
5. Li, G., and Zhang, X. C. (2004) GTP hydrolysis mechanism of Ras-like GTPases. J. Mol. Biol. 340, 921-932
6. Scheele, J. S., Rhee, J. M., and Boss, G. R. (1995) Determination of absolute amounts of GDP and GTP-bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 92, 1097-1100
7. Plowman, S. J., Williamson, D. J., O'Sullivan, M. J., Doig, J., Ritchie, A. M., Harrison, D. J., Melton, D. W., Arends, M. J., Hooper, M. L., and Patek, C. E. (2003) While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol. Cell. Biol. 23, 9245-9250
8. Esteban, L. M., Vicario-Abejon, C., Fernandez-Salguero, P., Fernandez-Medarde, A., Swaminathan, N., Yienger, K., Lopez, E., Malumbres, M., McKay, R., Ward, J. M., et al. (2001) Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21, 1444-1452
9. de Castro, I. P., Diaz, R., Malumbres, M., Hernandez, M. I., Jagirdar, J., Jimenez, M., Ahn, D., and Pellicer, A. (2003) Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res. 63, 1615-1622
10. Wolfman, J. C., and Wolfman, A. (2000) Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J. Biol. Chem. 275, 19315-19323
11. Wolfman, J. C., Palmby, T., Der, C. J., and Wolfman, A. (2002) Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol. Cell. Biol. 22, 1589-1606
12. Liao, J., Wolfman, J. C., and Wolfman, A. (2003) K-ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts. J. Biol. Chem. 278, 31871-31878
13. Matsui, T., Kinoshita, T., Morikawa, Y., Tohya, K., Katsuki, M., Ito, Y., Kamiya, A., and Miyajima, A. (2002) K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J. 21, 1021-1030
14. Kremer, N. E., D'Arcangelo, G., Thomas, S. M., DeMarco, M., Brugge, J. S., and Halegoua, S. (1991) Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions. J. Cell Biol. 115, 809-819
15. Baltus, E., Hanocq-Quertier, J., Hanocq, F., and Brachet, J. (1998) Injection of an antibody against a p21 c-Ha-ras protein inhibits cleavage in axolotl eggs. Proc. Natl. Acad. Sci. USA 85, 502-506
16. Mulcahy, L. S., Smith, M. R., and Stacey, D. W. (1985) Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (London) 313, 241-243
17. Dobrowolski, S., Harter, M., and Stacey, D. W. (1994) Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14, 5441-5449
18. Howe, P. H., Dobrowolski, S. F., Reddy, K. B., and Stacey, D. W. (1993) Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity. J. Biol. Chem. 268, 21448-21452
19. Swan, K. A., Alberola-Ila, J., Gross, J. A., Appleby, M. W., Forbush, K. A., Thomas, J. F., and Perlmutter, R. M. (1995) Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14, 276-285
20. Iritani, B. M., Forbush, K. A., Farrar, M. A., and Perlmutter, R. M. (1997) Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16, 7019-7031
21. D'Arcangelo, G., and Halegoua, S. (1993) A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell. Biol. 13, 3146-3155
22. Stacey, D. W., Feig, L. A., and Gibbs, J. B. (1991) Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11, 4053-4064
23. Kaplan, J. B. (1994) Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation. Oncol. Res. 6, 611-615
24. Aktas, H., Cai, H., and Cooper, G. M. (1997) Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17, 3850-3857
25. Chen, G., Oh, S., Monia, B. P., and Stacey, D. W. (1996) Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. J. Biol. Chem. 271, 28259-28265
26. Sharpe, C. C., Dockrell, M. E., Noor, M. I., Monia, B. P., and Hendry, B. M. (2000) Role of Ras isoforms in the stimulated proliferation of human renal fibroblasts in primary culture. J. Am. Soc. Nephrol. 11, 1600-1606
27. Sharpe, C. C., Dockrell, M. E., Scott, R., Noor, M. I., Cowsert, L. M., Monia, B. P., and Hendry, B. M. (1999) Evidence of a role for Ki-Ras in the stimulated proliferation of renal fibroblasts. J. Am. Soc. Nephrol. 10, 1186-1192
28. Taylor, S. J., and Shalloway, D. (1996) Cell cycle-dependent activation of Ras. Curr. Biol. 6, 1621-1627
29. Gille, H., and Downward, J. (1999) Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274, 22033-22040
30. Takuwa, N., and Takuwa, Y. (1997) Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated N1H 3T3 fibroblasts. Mol. Cell. Biol. 17, 5348-5358
31. Sa, G., Hitomi, M., Harwalkar, J., Stacey, A. W., Chen, G., and Stacey, D. W. (2002) Ras is active throughout the cell cycle, but is able to induce cyclin D1 only during G2 phase. Cell Cycle 1, 50-58
32. Crespo, P., and Leon, J. (2000) Ras proteins in the control of the cell cycle and cell differentiation. Cell. Mol. Life. Sci. 57, 1613-1636
33. Thrane, E. V., Becher, R., Lag, M., Refsnes, M., Huitfeldt, H. S., and Schwarze, P. E. (1997) Differential distribution and increased levels of ras proteins during lung development. Exp. Lung Res. 23, 35-49
34. Pells, S., Divjak, M., Romanowski, P., Impey, H., Hawkins, N. J., Clarke, A. R., Hooper, M. L., and Williamson, D. J. (1997) Developmentally-regulated expression of murine K-ras isoforms. Oncogene 15, 1781-1786
35. Sithanandam, G., Ramakrishna, G., Diwan, B. A., and Anderson, L. M. (1998) Selective mutation of K-ras by N-ethylnitrosourea shifts from codon 12 to codon 61 during fetal mouse lung maturation. Oncogene 17, 493-502
36. Ramakrishna, G., Sithanandam, G., Cheng, R. Y., Fornwald, L. W., Smith, G. T., Diwan, B. A., and Anderson, L. M. (2000) K-ras p21 expression and activity in lung and lung tumors. Exp. Lung Res. 26, 659-671
37. Kammouni, W., Ramakrishna, G., Sithanandam, G., Smith, G. T., Fornwald, L. W., Masuda, A., Takahashi, T., and Anderson, L. M. (2002) Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence. Cell. Growth. Differ. 13, 441-448
38. Chaturvedi, V., Cesnjaj, M., Bacon, P., Panella, J., Choubey, D., Diaz, M. O., and Nickoloff, B. J. (2003) Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes. Am. J. Pathol. 162, 161-170
39. Feig, L. A. (1999) Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat. Cell Biol. 1, E25-E27
40. Spandidos, A., and Wilkie, N. M. (1988) The normal human H-ras1 gene can act as an onco-suppressor. Br. J. Cancer Suppl. 9, 67-71
41. Spandidos, D. A., Frame, M., and Wilkie, N. M. (1990) Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes. Anticancer Res. 10, 1543-1554
42. Zhang, Z., Wang, Y., Vikis, H. G., Johnson, L., Liu, G., Li, J., Anderson, M. W., Sills, R. C., Hong, H. L., Devereux, T. R., et al. (2001) Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29, 25-33
43. Diaz, R., Ahn, D., Lopez-Barcons, L., Malumbres, M., Perez de Castro, I., Lue, J., Ferrer-Miralles, N., Mangues, R., Tsong, J., Garcia, R., et al. (2002) The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res. 62, 4514-4518
44. Delgado, M. D., Vaque, J. P., Arozarena, I., Lopez-Ilasaca, M. A., Martinez, C., Crespo, P., and Leon, J. (2000) H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism. Oncogene 19, 783-790
45. James, R. M., Arenas, M. J., Plowman, S. J., Brooks, D. G., Miles, C. G., West, J. D., and Patek, C. E. (2003) K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratonias. Mol. Cancer Res. 11, 820-825
46. Guerrero, I., Villasante, A., Corces, V., and Pellicer, A. (1985) Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc. Natl. Acad. Sci. USA 82, 7810-7814
47. Bremner, R., and Balmain, A. (1990) Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61, 407-417
48. Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., and Jacks, T. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature (London) 410, 1111-1116
49. Takeuchi, S., Mod, N., Koike, M., Slater, J., Park, S., Miller, C. W., Miyoshi, I., and Koeffler, H. P. (1996) Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res. 56, 38-740
50. Sanchez-Cespedes, M., Ahrendt, S. A., Piantadosi, S., Rosell, R., Monzo, M., Wu, L., Westra, W. H., Yang, S. G., Jen, J., and Sidransky, D. (2001) Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res. 61, 1309-1313
51. Kibel, A. S., Schutte, M., Kern, S. E., Isaacs, W. B., and Bova, G. S. (1998) Identification of 12p as a region of frequent deletion in advanced prostate cancer. Cancer Res. 58, 5652-5655
52. Mahlamaki, E. H., Hoglund, M., Gorunova, L., Karhu, R., Dawiskiba, S., Andren-Sandberg, A., Kallioniemi, O. P., and Johansson, B. (1997) Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 20, 383-391
53. Sourvinos, G., Kiaris, H., Tsikkinis, A., Vassilaros, S., and Spandidos, D. A. (1997) Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumour Biol. 18, 157-166
54. Baccichet, A., and Sinnett, D. (1997) Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia. Br. J. Haematol. 99, 107-114
55. Tsunematsu, S., Saito, H., Kagawa, T., Morizane, T., Hata, J., Nakamura, T., Ishii, H., Tsuchiya, M., Nomura, T., and Katsuki, M. (1994) Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c-H-ras proto-oncogene without mutations. Int. J. Cancer 59, 554-559
56. Maruyama, C., Tomisawa, M., Wakana, S., Yamazaki, H., Kijima, H., Suemizu, H., Ohnishi, Y., Urano, K., Hioki, K., Usui, T., et al. (2001) Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice. Oncol. Rep. 8, 233-237
57. Ise, K., Nakamura, K., Nakao, K., Shimizu, S., Harada, H., Ichise, T., Miyoshi, J., Gondo, Y., Ishikawa, T., Aiba, A., et al. (2000) Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19, 2951-2956
58. Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) Endogenous oncogenic K-ras (G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 4, 375-387
59. Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450
60. Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., and Barbacid, M. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4, 111-120
61. Diaz, R, Lopez-Barcons, L., Ahn, D., Garcia-Espana, A., Yoon, A., Matthews, J., Mangues, R., Perez-Soler, R., and Pellicer, A. (2004) Complex effects of Ras proto-oncogenes in tumorigenesis. Carcinogenesis. 25, 535-539
62. Pils, B., and Schultz, J. (2004) Inactive enzyme-homologues find new function in regulatory processes. J. Mol. Biol. 340, 399-404
63. Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., and Noda, M. (1989) A ras-related gene with transformation suppressor activity. Cell 56, 77-84
64. Fisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., Whitsett, J. A., Koretsky, A., and Varmus, H. E. (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15, 3249-3262
65. Uchiyama, M., Usami, N., Kondo, M., Mori, S., Ito, M., Ito, G., Yoshioka, H., Imaizumi, M., Ueda, Y., Takahashi, M., et al. (2003) Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer. Int. J. Cancer 107, 962-969
66. Finney, R. E., and Bishop, J. M. (1993) Predisposition to neoplastic transformation caused by gene replacement of H-ras1. Science 260, 1524-1527
67. Cichutek, K., and Duesberg, P. H. (1989) Recombinant BALB and Harvey sarcoma viruses with normal proto-ras-coding regions transform embryo cells in culture and cause tumors in mice. J. Virol. 63, 1377-1383
68. Stewart, S., and Guan, K. L. (2000) The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation. J. Biol. Chem. 275, 8854-8862
69. Romero, F., Martinez-A, C., Camonis, J., and Rebollo, A. (1999) Aiolos transcription factor controls cell death in T cells by regulating Bel-2 expression and its cellular localization. EMBO J. 18, 3419-3430
70. Ortiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X. F., Dammann, R., Pfeifer, G. P., and Avruch, J. (2002) The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene 21, 1381-1390
71. Nehrbass, U., and Blobel, G. (1996) Role of the nuclear transport factor p10 in nuclear import. Science 272, 120-122
72. Park, H. O., Bi, E., Pringle, J. R., and Herskowitz, I. (1997) Two active states of the Ras-related Bud1/Rsr1 protein bind to different effectors to determine yeast cell polarity. Proc. Natl. Acad. Sci. USA 94, 4463-4468
73. Tarricone, C., Xiao, B., Justin, N., Walker, P. A., Rittinger, K., Gamblin, S. J., and Smerdon, S. J. (2001) The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signalling pathways. Nature (London) 411, 215-219
74. Sigal, N., Gorzalczany, Y., Sarfstein, R., Weinbaum, C., Zheng, Y., and Pick, E. (2002) The guanine nucleotide exchange factor trio activates the phagocyte NADPH oxidase in the absence of GDP to GTP exchange on Rac. "The emperor's new clothes". J. Biol. Chem. 278, 4854-4861
75. Tian, D., Litvak, V., Toledo-Rodriguez, M., Cannon, S., and Lev, S. (2002) Nir2, a novel regulator of cell morphogenesis. Mol. Cell. Biol. 22, 2650-2662
76. Fukuda, M. (2003) S1p4-a/granuphilin-a inhibits dense-core vesicle exocytosis through interaction with the GDP-bound form of Rab27A in PC12 cells. J. Biol. Chem. 278, 15390-15396
77. Hamilton, M., Liao, J., Cathcart, M. K., and Wolfman, A. (2001) Constitutive association of c-N-Ras with c-Ral-1 and protein kinase C epsilon in latent signaling modules. J. Biol. Chem. 276, 29079-29090
78. Chen, J. M., Friedman, F. K., Brandt-Rauf, P. W., Pincus, M. R., and Chie, L. (2002) Comparison of the average structures, from molecular dynamics, of complexes of GT-Pase-activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains. J. Protein Chem. 21, 349-359
79. Kanovsky, M., Michl, J., Botzolaki, G., Morin, J., Kovac, C., Chung, D. L., Chie, L., Friedman, F. K., and Pincus, M. R. (2003) Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth. Cancer Chemother. Pharmacol. 52, 202-208
80. Adler, V., Pincus, M. R., Brandt-Rauf, P. W., and Ronai, Z. (1995) Complexes of p21RAS with JUN N-terminal kinase and JUN proteins. Proc. Natl. Acad. Sci. USA 92, 10585-10589
81. Vos, M. D., Ellis, C. A., Elam, C., Ulku, A. S., Taylor, B. J., and Clark, G. J. (2003) RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J. Biol. Chem. 278, 28045-28051
82. Chie, L., Qu, Y., Chung, D., Boutjdir, M., and Pincus, M. R. (2003) Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction. J. Protein Chem. 22, 625-629
83. Lucas, L., Penalva, V., Ramirez, de Molina, A., Del Peso, L., and Lacal, J. (2000) Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1. Int. J. Oncol. 21, 477-485
84. Chie, L., Cook, J. R., Chung, D., Hoffmann, R., Yang, Z., Kim, Y., Pestka, S., and Pincus, M. R. (2003) A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction. Ann. Clin. Lab. Sci. 33, 200-207
85. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
86. Deng, Q., Liao, R., Wu, B. L., and Sun, P. (2004) High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J. Biol. Chem. 279, 1050-1059
87. Ranginwale, M., Smith, S., Flom, J., Chie, L., Kanovsky, M., Chung, D., Friedman, F. K., Robinson, R. C., Brandt-Rauf, P. W., Yamaizumi, Z., et al. (2001) Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes. Exp. Cell Res. 269, 162-169